LamdaGen Corporation is an innovative technology company at the forefront of developing and integrating powerful plasmonic biosensors for a wide range of applications. Our primary focus is on enabling rapid point-of-use diagnostic and detection systems that require exceptional sensitivity and precise quantitation. To achieve this, we have developed the LAuRA Digital Diagnostic System, which utilizes our proprietary plasmonic biosensors as the core technology, supported by our patented Plasmonic Amplification Technology™ (PAT™). PAT represents a significant breakthrough in the realm of rapid, high-sensitivity detection, featuring a unique double amplification system. This technology allows our products to combine the speed and convenience of lateral flow assay (LFA) technologies with the exceptional sensitivity and quantitation capabilities of microtiter plate enzyme-linked immunosorbent assays (ELISA). As a technology holding company, LamdaGen follows a serial spin-off licensing model to optimize the value of our biosensor-based technologies. We leverage our expertise and intellectual property to expand into various sectors, including Food and Water Safety, Human Health, Animal Health, and Environmental Health. Through strategic partnerships with industry leaders in these sectors, we are applying our powerful biosensor technology to a broad range of applications, facilitating significant advancements in diagnostic capabilities and enhancing overall safety and well-being. At LamdaGen, our vision is to revolutionize the field of biosensing by consistently pushing the boundaries of sensitivity, speed, and precision for commercial use. We remain committed to delivering cutting-edge solutions that address critical needs across diverse industries, ultimately improving health outcomes and enabling more effective decision-making processes. We invite you to explore partnering opportunities with us.
View Top Employees from LamdaGen CorporationWebsite | http://lamdagen.com/ |
Revenue | $4 million |
Employees | 5 (4 on RocketReach) |
Founded | 2004 |
Address | 1455 Adams Drive Ste 1155, Menlo Park, California 94025, US |
Phone | (650) 571-5816 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Biotechnology, Manufacturing General, Manufacturing, Science and Engineering, Health Care, Information Technology, Software |
Web Rank | 28 Million |
Competitors | Attana, BIOLAN Microbiosensors, NANOARC, SRU Biosystems, Strella |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 325413 Companies, NAICS Code 3254 Companies |
Looking for a particular LamdaGen Corporation employee's phone or email?
The LamdaGen Corporation annual revenue was $4 million in 2024.
Alice Huang is the Vice President Operations of LamdaGen Corporation.
4 people are employed at LamdaGen Corporation.
LamdaGen Corporation is based in Menlo Park, California.
The NAICS codes for LamdaGen Corporation are [32541, 32, 325, 325413, 3254].
The SIC codes for LamdaGen Corporation are [28, 283].